Previous close | 426.40 |
Open | 426.40 |
Bid | 385.00 |
Ask | 394.00 |
Strike | 590.00 |
Expiry date | 2025-12-19 |
Day's range | 426.40 - 426.40 |
Contract range | N/A |
Volume | |
Open interest | N/A |
First Quarter Results Show Revenue Decline but Strong Dupixent and Libtayo Sales Growth
It is hard to get excited after looking at Regeneron Pharmaceuticals' (NASDAQ:REGN) recent performance, when its stock...
Regeneron Pharmaceuticals earnings and sales missed first-quarter estimates early Thursday. Shares fell slightly.